This inventor holds 2 USPTO granted patents. Top assignee: Nicholas Piramal India Limited. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2007
Title: Innovations by Rajender Pershad Gupta
Introduction
Rajender Pershad Gupta is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing important medicinal compounds. With a total of two patents to his name, Gupta's work has the potential to impact the treatment of various cerebral diseases.
Latest Patents
Gupta's latest patents include a process for the preparation of Gabapentin, which is a crucial drug used in the treatment of epilepsy. This innovative process involves converting gabapentin hydrochloride salt into gabapentin using an inorganic base, such as barium hydroxide. The method enhances the industrial feasibility and effectiveness of gabapentin manufacture. His second patent focuses on the manufacture of phenyl ethylamine compounds, particularly venlafaxine. This process involves the alkylation of precursor amines, utilizing Raney Nickel as a catalyst, to produce hydroxy(cycloalkane/cyclokene) phenylethyl amine.
Career Highlights
Rajender Pershad Gupta is currently associated with Nicholas Piramal India Limited, a prominent player in the pharmaceutical industry. His work at the company has allowed him to explore innovative solutions in drug manufacturing, contributing to advancements in medical treatments.
Collaborations
Gupta has collaborated with notable coworkers, including Jagdish Chand Saigal and Rajesh Vinodrai Naik. These collaborations have fostered a productive environment for innovation and development within the pharmaceutical sector.
Conclusion
Rajender Pershad Gupta's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in drug manufacturing and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile